References
1. Israel CW, Grönefeld G, Ehrlich JR, et al. Long-Term Risk of Recurrent Atrial Fibrillation as Documented by an Implantable Monitoring Device: Implications for Optimal Patient Care. J Am Coll Cardiol 2004; 43: 47-52.
2. Kim BS, Chun KJ, Park S, et al. Predictors and long-term clinical outcomes of newly developed atrial fibrillation in patients with cardiac implantable electronic devices. Medicine 2016; 95: 28
3. Ogino Y, Ishikawa T, Ishigami T, et al. Characteristics and Prognosis of Pacemaker-Identified New-Onset Atrial Fibrillation in Japanese People. Circ J 2017; 81: 794-798.
4. Glotzer TV, Daoud EG, Wyse DG, et al. The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: The TRENDS study. Circ Arrhythmia Electorophysiol 2009; 2: 474–481.
5. Healey J, Connolly S, Gold M, et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 2012; 366: 120–129.
6. Dilaveris PE, Gialafos JE. P Wave Dispersion : A Novel Predictor of Paroxysmal Atrial Fibrillation. Ann Noninvas Electro 2001; 6: 159-165
7. Lazzeroni D, Parati G, Bini M, et al. P-wave dispersion predicts atrial fibrillation following cardiac surgery. Int J Cardiol 2016; 203: 131-133.
8. Yoshizawa T, Niwano S, Niwano H, et al. Prediction of New Onset Atrial Fibrillation Through P Wave Analysis in 12 Lead ECG. Int Heart J 2014; 55: 422-427.
9. Dogan A, Avsar A, Ozturk M. P-wave dispersion for predicting maintenance of sinus rhythm after cardioversion of atrial fibrillation. Am J Cardiol 2004; 93: 368-371
10. Perzanowski C, Ho AT, Jacobson AK. Increased P-wave dispersion predicts recurrent atrial fibrillation after cardioversion. J. Electrocardiol 2005; 38: 43-46.
11. Epstein AE, Dimarco JP, Ellenbogen KA, et al. 2012 ACCF / AHA / HRS Focused Update Incorporated Into the ACCF / AHA / HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities. Circulation 2013; 127: e283-e352.
12. Kuria T, Nogami A, Abe H, et al. JCS Guideline on Non-Pharmacotherapy of Cardiac Arrhythmias (JCS2018): 1-162
13. Pollak WM, Simmons JD, Interian A, et al. Clinical Utility of Intraatrial Pacemaker Stored Electrograms to Diagnose Atrial Fibrillation and Flutter. PACE 2001; 24: 424-429
14. Aytemir K, Ozer N, Atalar E, Sade E. P wave dispersion on 12-lead electrocardiography in patients with paroxysmal atrial fibrillation. PACE 2000; 23: 1109–1112.
15. Andrikopoulos GK, Dilaveris PE, Richter DJ. Increased variance of P wave duration on the electrocardiogram distinguishes patient
with idiopathic paroxysmal atrial fibrillation. PACE 2000; 23: 1127–1132.
16. Dilaveris PE, Gialafos E, Sideris S. Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial
fibrillation. Am Heart J. 1998; 135: 73–78.
17. Chang CM, Lee SH, Lu MJ, et al. The role of P wave in prediction of atrial fibrillation after coronary artery surgery. Int J Cardiol
1999; 68: 303–308
18. Yamada T, Fukunami M, Shimonagata T, et al. Dispersion of signal-averaged P wave duration on precordial body surface in
patients with paroxysmal atrial fibrillation. Eur Heart J 1999; 20: 211-220.
19. Wang TJ, Larson MG, Levy D, et al. Temporal Relations of atrial fibrillation and congestive heart failure and their joint influence on mortality The Framingham Heart Study. Circulation 2003; 107: 2920-2925.
20. Glotzer TV., Hellkamp AS, Zimmerman J, et al. Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: Report of the atrial diagnostics ancillary study of the MOde Selection Trial (MOST). Circulation 2003; 107: 1614-1619.
21. Cheung JIMW, Keating RJ, Stein KM, et al. Newly Detected Atrial Fibrillation Following Dual Chamber Pacemaker Implantation. J Cardiovasc Electrophysiol 2006; 17: 1323-1328
22. Orlov MV, Ghali JK, Araghi-Niknam M, et al. Asymptomatic atrial fibrillation in pacemaker recipients: Incidence, progression, and determinants based on the atrial high rate trial. Pacing Clin Electrophysiol 2007; 30: 404–411.
23. Radeljić V, Pavlović N, Manola Š, et al. Incidence and predictors of asymptomatic atrial fibrillation in patients older than 70 years with complete atrioventricular block and dual chamber pacemaker implantation. Croat Med J 2011; 52: 61-67.
24. Skanes AC, Krahn AD, Yee R, et al. Progression to chronic atrial fibrillation after pacing : The Canadian Trial of Physiologic Pacing. J Am Coll Cardiol 2001; 38: 167-172
25. Li G, Liu E, Liu T, et al. Atrial electrical remodeling in a canine model of sinus node dysfunction. Int J Cardiol 2011; 146: 32-36.
26. Andres Ricardo Perez-Riera, Luiz Carlos de Abreu, Raimundo Barbosa-Barros, et al. P-wave dispersion : an update. Indian Pacing Electrophysiol J 2016; 16: 126-133
27. Nishinarita R, Niwano S, Fukaya H, et al. Burden of implanted-device-detected atrial high-rate episode is associated with future heart failure events - Clinical Significance of asymptomatic atrial fibrillation in patients with implantable cardiac electronic devices. Circ J 2019; 83: 736-742